Introduction With the advancements in early diagnosis, more and more patients with multiple
primary lung cancer (MPLC) have been identified. However, the progression of MPLC …

Tumor immune microenvironment (TIME) and its indications for lung cancer patient
prognosis and therapeutic response have become new hotspots in cancer research in …

The incidence of lung cancer continues to grow globally, contributing to an ever-increasing
load on healthcare systems. Emerging evidence has indicated lowered efficacy of …

Brain metastasis occurs in approximately 30% of patients with lung adenocarcinoma (LUAD)
and is closely associated with poor prognosis, recurrence, and death. However, dynamic …

The detection rate of ground glass nodules (GGNs) has increased in recent years because
of their malignant potential but relatively indolent biological behavior; thus, correct GGN …

Multiple synchronous lung cancers (MSLCs) constitute a unique subtype of lung cancer. To
explore the genomic and immune heterogeneity across different pathological stages of …

This expert consensus reviews current literature and provides clinical practice guidelines for
the diagnosis and treatment of multiple ground glass nodule-like lung cancer. The main …

Background: Lung adenocarcinoma is a very pervasive histological form of lung cancers,
and inhibiting metastasis is crucial for effective treatment. In this investigation, we explored …

Objective To assess the clinical efficacy and side effects of EGFR-TKI with or without
chemotherapy in the treatment of EGFR mutation-positive advanced lung adenocarcinoma …

The progression of multiple primary lung cancer (MPLC) involves complex changes in cell
composition and metabolic function. Here, we performed scRNA sequencing of 167,397 …